GlobeNewswire 5/9/2018 BioLargo reduces balance sheet liabilities by more than $5,400,000
GlobeNewswire 4/19/2018 BioLargo, Inc. CEO Dennis Calvert Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
GlobeNewswire 4/19/2018 GB Sciences, CEO, John Poss, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
GlobeNewswire 4/18/2018 BioLargo’s Canadian Subsidiary Receives Funding from the Government of Canada for AOS Pilot Project
GlobeNewswire 3/9/2018 Dennis Calvert, CEO of BioLargo Inc., Returns to Uptick Newswire's "Stock Day" Podcast
GlobeNewswire 2/6/2018 BioLargo Completes Study of Breakthrough Water Treatment Technology for Poultry Process Water and Mu...
GlobeNewswire 2/1/2018 BioLargo Inc. CEO, Dennis Calvert, Returns to Uptick Newswire’s “Stock Day” Podcast for a Company Up...
GlobeNewswire 12/4/2017 BioLargo, Inc. to Present at 10th Annual LD Micro Investor Conference on its Disruptive Clean Water,...
GlobeNewswire 11/14/2017 BioLargo Sets New Sales Records and Continues to Break Through Commercial Barriers
GlobeNewswire 11/13/2017 UPDATE – Uppie Award Winners and Show Recap
GlobeNewswire 11/13/2017 Uppie Award Winners and Show Recap
GlobeNewswire 10/16/2017 BioLargo receives OCTANe 2017 High Tech Innovation Award
GlobeNewswire 9/28/2017 BioLargo's Medical Subsidiary Files 510(k) with FDA for its Novel Wound Care Technology
GlobeNewswire 9/20/2017 BioLargo CEO Dennis Calvert Elaborates on the Importance of its new Engineering Division and Financi...
GlobeNewswire 9/11/2017 BioLargo Acquires World-Class Engineering Team to Form a New Engineering Services Subsidiary and Ent...
GlobeNewswire 8/28/2017 CEO Dennis Calvert Gives a Personal Interview on the Symposium’s Positive Outcome and BioLargo’s Cur...
GlobeNewswire 8/22/2017 BioLargo’s 3rd Annual Technical Symposium Showcases its Advanced Oxidation System (AOS) and First Co...
GlobeNewswire 8/15/2017 BioLargo Achieves Important Milestones - Sales Increase by 176%